1Gharib H, Turtle RM, Baskin ILl, et al. Consensus Statement #1 : Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and the Endocrine Society[J]. Thyroid,2005, 15(1):24-28.
2Duntas LH, Wartofsky L. Cardiovascular risk and subclicical hypothyroidism : focus on lipids and new emerging risk factors. What is the evidence? [J]. Thyroid, 2007,17(11 ) : 1075-1084.
3Velkoska Nakova V, Krstevska B, Bosevski M, et al. Dyslipidaemia and hypertension in patients with subclicical hypothyroidism[J]. Prilozi,2009,30 (2) : 93-102.
4Turhan S, Sezer S, Erden G, et al. Plasma homocysteine concentrations and serum lipid profile as atherosclerotic risk factors in subclinical hypothyroidism [J]. Ann Saudi Med, 2008,28(2) :96-101.
5Hueston WJ, Pearson WS. Subclinicalhypothyroidism and the risk of hypercholesterolemia [J]. Ann Fam Med, 2004,2(4) :351-355.
6Walsh JP, Bremner AP, Bulsara MK, et al. Thyroid dysfunction and serum lipids: a community-based study[J]. Clin Endocrinol (Oxf), 2005,63 (6) : 670-675.
7Canaris GJ, Manowitz NR, Mayor G, et al. The Colorado thyroid disease prevalence study[J]. Arch Intern Med, 2000,160 (4) : 526-534.
8Milionis HJ, Efstathiadou Z, Tselepis AD, et al. Lipoprotein (a) levels and apolipoprotein(a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine [J]. Thyroid, 2003,13(4) :365-369.
5Danbaek L, Jorgensen LM. Screening for thyroid disease. Occurrence of hypothyroidism and hyperthyroidism in patients admitted to a geriatric department. Ugeskr Laeger. 2001, 163:5665.
6Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab, 2003,88:2438-2444.
7Hak AE, Pols HAP, Visser TJ, et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med, 2000,132:270-278.
8Bonetti PO, Lerman LO, Lerman A. Endothelial dysfunction, a marker of atherosclerotic risk. Arterioscler Thromb Vasc Biol, 2003,23:168-175.
9Ross R. The pathogenesis of atherosclerosis-an update. N Engl J Med,1986,314:488-500.
10Mclenacham JM, Vita J, Fish DR, et al. Early evidence of endothelial vasodilator dysfunction at coronary branch points. Circulation, 1990,82:1169-1173.
10Razvi S, Weaver IU, Vanderpump MP, et al. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort[I]. ] Clin Endocrinol Metab, 2010, 95(4): 1734-1740.
